AQR Capital Management’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,957
Closed -$123K 3213
2024
Q4
$123K Sell
11,957
-1,095
-8% -$10.6K ﹤0.01% 2743
2024
Q3
$124K Sell
13,052
-7,767
-37% -$67K ﹤0.01% 2635
2024
Q2
$177K Sell
20,819
-36,554
-64% -$334K ﹤0.01% 2440
2024
Q1
$531K Buy
57,373
+20,655
+56% +$182K ﹤0.01% 1941
2023
Q4
$356K Sell
36,718
-47,692
-57% -$445K ﹤0.01% 2010
2023
Q3
$757K Buy
84,410
+15,669
+23% +$149K ﹤0.01% 1704
2023
Q2
$771K Buy
68,741
+50,581
+279% +$448K ﹤0.01% 1660
2023
Q1
$191K Buy
18,160
+6,950
+62% +$76.6K ﹤0.01% 2057
2022
Q4
$108K Buy
+11,210
New +$126K ﹤0.01% 2134

Other funds holding ENFN

AQR Capital Management's ENFN Position: Q1 2025 in Review

AQR Capital Management sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 11,957 shares — an estimated $123K sold.

AQR Capital Management first reported a position in ENFN in Q4 2022 and held it in 9 quarters. The position peaked at $771K in Q2 2023. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

  • AQR Capital Management reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
  • AQR Capital Management sold 11,957 Enfusion, Inc. shares in Q1 2025, an estimated $123K.
  • AQR Capital Management first reported a position in Enfusion, Inc. in Q4 2022 and held it in 9 quarters.
  • AQR Capital Management's Enfusion, Inc. position peaked at $771K in Q2 2023.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on AQR Capital Management's 13F filing for Q1 2025, filed 15 May 2025.